[Sanitation results in chronic typhus and paratyphus B carriers using trimethoprim-sulfamethoxazole].
D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002353:Carrier State / Q000175:diagnosis / Q000188:drug therapy*; D002765:Cholecystography; D004338:Drug Combinations; D004386:Duodenum / Q000382:microbiology; D005243:Feces / Q000382:microbiology; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007419:Intestinal Secretions / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D010284:Paratyphoid Fever / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use; D014438:Typhus, Epidemic Louse-Borne / Q000188:drug therapy*
D000890:Anti-Infective Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Sanierungsergebnisse an Typhus- und paratyphus-B-Dauerausscheiden mit Trimethopri-Sulfamethoxazol.